The Tokyo stock market fell due to worries about China. Photograph: Kimimasa Mayama/EPA
Sell in May and go away, don’t come back until St Leger Day. So goes the old stock market adage and rarely has the first part of that advice been more apposite than this year. The FTSE 100 index peaked on 27 April, just before the general election, […]
Sometimes it helps to take look the world through an unconventional perspective when thinking about the size of things.So here’s a pretty awesome map from Bank of America Merrill Lynch’s Chief Investment Strategist Michael Hartnett that shows the world according to free-float equity market capitalization in billions of dollars measured by the MSCI.The US, with a market cap of $19.8 trillion, is the […]
Related CLVSClovis Oncology Could Pass $100 By Year-End: Here’s WhyClovis Oncology Completes US, EU Regulatory Submissions for Rociletinib for Treatment of Advanced EGFR-Mutant T790M+ NSCLCClovis Oncology: Don’t Discount Rociletinib’s Chances Against AZD9291(Seeking Alpha)Related EPZMBenzinga’s Top DowngradesH.C. Wainwright Destroys Epizyme Price Target, Sees ‘No Material Value Drivers’A new report by Mizuho analyst Peter Lawson focuses on biotech stocks with major catalysts […]
Via Dana Lyons’ Tumblr,.50-day “droughts” before and after a 52-week high in the Dow Jones Industrial Average have marked several major tops.It has now been 64 days since the last 52-week high in the Dow Jones Industrial Average (DJIA) on May 19. While that may seem like an eternity in the context of the past 2.5 years, it’s not at […]
A shop worker in Jakarta, Indonesia, counts rupiah after a big fall in its value amid increasing fears for the health of the Chinese economy Photograph: Bay Ismoyo/AFP/Getty Images
China slowdownChina’s continued growth helped limit the impact of the global recession of 2009 but now fears are increasing that the world’s second-biggest economy could cause the next recession. China’s growth is […]
By
Timothy Hay
Biography
CONNECT
Biography
Venrock
With biotechnology stocks turning in stellar performances on the Nasdaq Global Exchange and digital-health startups commanding huge funding rounds at high valuations, some are talking about a bubble forming in certain areas of medical technology.But Bryan Roberts of Venrock, who last year logged six successful exits from medical technology investments, doesn’t use the word “bubble.”The industry, he said, is […]
Investors have been flocking to biotech stocks this year, with the IBB, the ETF that tracks biotech stocks, making noteworthy gains. So far in 2015, several industries have either underperformed or provided mixed results, leading to a rather ho-hum showpiece for U.S. blue-chip indices.Biotech stocks, on the other hand, have consistently returned positive results in the markets over the past […]
They say good things come in threes. If so, biotech companies could be in for not just another year of outperformance, but another decade. The first era of biotech was a building phase, when companies created their first blockbuster drugs. The second, current one, has resulted in a four-year rally that reflects the sector’s transition from a cluster of one-hit […]
If there is such a thing as a poster child for volatility in the stock market, the biotech sector would likely take top honors.Biotech stocks are unique. While stocks in other sectors are typically valued based on their past performance and future earnings potential, the majority of biotech stocks don’t have a cent in recurring revenue. Instead, biotech stocks are […]
Many individual investors have opted to invest in biotech ETFs and mutual funds. The XBI and SBIO funds have performed well because they focus more on small and mid-sized biotech companies. The IBB, which has emerged as something of a proxy for the industry for many investors, is weighted much more heavily to bigger, more proven biotech companies.The volatility of […]
